Cargando…
Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for 85~90% of lung cancer cases, with a poor prognosis and a low 5-year survival rate. Sphingosine kinase-1 (SPHK1), a key enzyme in regulating sphingolipid metabolism, has been reported to be involved in the development of NSCLC, although the underlying m...
Autores principales: | Lin, Zhoujun, Li, Yin, Han, Xiao, Fu, Zhenkun, Tian, Zhenhuan, Li, Chenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657307/ https://www.ncbi.nlm.nih.gov/pubmed/36361531 http://dx.doi.org/10.3390/ijms232112741 |
Ejemplares similares
-
Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)
por: Li, Fei, et al.
Publicado: (2022) -
Identification of PBX1 Target Genes in Cancer Cells by Global Mapping of PBX1 Binding Sites
por: Thiaville, Michelle M., et al.
Publicado: (2012) -
SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis
por: Qin, Zijia, et al.
Publicado: (2021) -
Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review
por: Yang, Mao, et al.
Publicado: (2022) -
Cardiac Toxicity From Adjuvant Targeting Treatment for Breast Cancer Post-Surgery
por: Fu, Zhenkun, et al.
Publicado: (2022)